Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)

Market Cap	3.79B -9.1%
Revenue (ttm)	351.25M +0.6%
Net Income	7.10M -32.8%
EPS	0.03 -29.5%
Shares Out	219.47M
PE Ratio	534.69
Forward PE	n/a
Dividend	1.20 (7.31%)
Ex-Dividend Date	Jun 12, 2025

Volume	14,423,223
Average Volume	5,915,761
Open	15.70
Previous Close	16.05
Day's Range	15.70 - 17.45
52-Week Range	15.28 - 23.28
Beta	0.31
RSI	46.21
Earnings Date	Apr 24, 2026

About SHE:002932

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents and diagnostic instruments in China. The company offers external diagnostic testing, third-party medical testing, certification consulting services, and medical information platform construction services. It also provides information software and supporting hardware products. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. was founded in 2008 and is based in Wuhan, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 812
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002932

Financial Performance

In 2024, SHE:002932's revenue was 350.06 million, a decrease of -53.30% compared to the previous year's 749.54 million. Earnings were 74.52 million, a decrease of -0.54%.